of 2025 announced new investments and affiliate sales, as well as the partial impact from our recently announced incremental investment in new investment in Highbrook. Combined, we expect these two newly announced transactions to add an incremental $20,000,000 to adjusted EBITDA on a full-year basis, a portion of which will be in Q1. Q1 fee-related earnings guidance of $270,000,000, which is our adjusted EBITDA guidance less net performance fees in the quarter, is a good starting point for purposes of modeling full-year 2026, incorporating all our capital allocation activity and organic growth in 2025, and represents 30% expected growth in quarterly fee-related earnings versus Q1 2025. As it relates to performance fees, we are starting the year from a solid point. Given our first-quarter guidance range, we expect net performance fee earnings of approximately $170,000,000 for 2026, which is consistent with our five-year average from 2021 to 2025. However, it is still early and we plan to provide an update later in the year. Overall, we continue to have significant capacity to execute on new investments beyond Garda and Highbrook that could further enhance Affiliated Managers Group, Inc.'s earnings power over time. Our capital allocation strategy together with strong organic growth in our existing business has driven growth in AUM, fee-related earnings, adjusted EBITDA, and economic earnings per share in 2025, and this momentum that we have built in our business has set the stage for meaningful growth potential in 2026 and beyond. Growth in alternatives in 2025 included substantial contributions from two of our largest affiliates, Pantheon and AQR, both of which were double-digit contributors to Affiliated Managers Group, Inc.'s earnings. Given their strong performance, ongoing innovation, and differentiated expertise, we expect a growing contribution in 2026, with AQR likely to contribute more than 20% to our earnings. Further, we continue to diversify our business through new partnerships, and we feel good about the opportunities ahead as we strategically engage with our new and existing affiliates. Finally, turning to the balance sheet and capital allocation. Our balance sheet is in a strong position given our long-dated debt, low leverage level, and access to our revolver. In August 2025, our ten-year senior $350,000,000 institutional bond matured and was repaid. In December 2025, we completed the issuance of a ten-year $425,000,000 senior note at a 5.5% coupon rate, and used the proceeds to redeem and settle conversions related to our 2037 junior convertible trust preferred securities, which were settled fully in cash in January 2026. The total cost to refinance the security was $516,000,000, which included $342,000,000 of debt and $174,000,000 of conversion premium. $174,000,000 of conversion premium effectively represents the repurchase of approximately 600,000 adjusted diluted shares at a stock price of $293. Given this occurred in Q1 of this year, you can still see these shares in our Q4 2025 average adjusted diluted shares outstanding. The share dilution associated with these securities has now been fully removed for purposes of our Q1 2026 share count guidance of 27,400,000. Together, these transactions resulted in a simplified balance sheet and removed share count dilution from our capital structure. 2025 was an active year for us in terms of capital allocation. We committed more than $1,000,000,000 to growth investments, which included new partnerships with Northbridge in Q1, Verition in Q2, and Qualitas Energy and Montefiore in Q4, plus our announced strategic collaboration with BBH Credit Partners. We repurchased $350,000,000 in shares in the fourth quarter, our largest quarterly repurchase amount in firm history, bringing full-year repurchases to approximately $700,000,000 for the second consecutive year. We received aggregate pretax proceeds of approximately $570,000,000 from the sale of our minority stakes in Peppertree, which closed in Q3, and Convest private credit business and Montrusco Bolton, both of which closed in Q4. These transactions represented positive outcomes for all stakeholders, and collectively supported our $1,700,000,000 growth capital deployment in 2025 across new investments and share repurchases. We have continued to actively allocate capital into 2026. We announced a new partnership with Highbrook and a follow-on investment in Garda. The combination of the $175,000,000 committed to new investments, which are immediately accretive to EBITDA, and the $174,000,000 conversion premium on the settlement of the trust preferred, which further reduces our share count, creates strong earnings momentum to start the year. As we have demonstrated over the years, we aim to maintain a balance of strong deployment of capital across both growth investments and return of capital to shareholders. Along these lines, we anticipate repurchasing at least $400,000,000 in shares in 2026, beyond the conversion premium on the trust preferred securities, subject to market conditions and capital allocation activity. This does not reflect our full deployment capacity and we plan to update everyone throughout the year as the quantum and pace of growth investments come into view. 2025 was a year in which every element of our growth strategy, from affiliate performance to organic growth to new affiliate investments and other growth investments, to share repurchases and effective capital management, all contributed to standout business results. And looking ahead, we are very excited to continue to build on this momentum in 2026. We have a diverse set of opportunities ahead of us, and we remain deliberate and disciplined in our approach to deploying capital. We have entered the year in a position of strength, and we are confident in our ability to continue to generate meaningful incremental value for our shareholders. We will now open for questions.